Value of color Doppler ultrasound in the treatment of recurrent melanoma with isolated limb perfusion

Purpose. To assess the effectiveness of Color Doppler Ultrasound (US) in the follow-up of recurrent melanoma of the limbs treated by isolated limb perfusion (ILP). Materials and methods. A retrospective study was done looking at 18 patients treated by isolated perfusion of the limb. Number, size and vascularity of subcutaneous metastases were examined for all patients. The results of pre and post therapeutic examinations were compared with clinical data and evolution. Results. US was superior to clinical examination in the detection and measurement of subcutaneous metastases. Decrease in tumor size and early disappearance of tumoral vascularity were associated with an effective tumor response to treatment. Early disappearance of vascularity was associated with early complete response. Initial presence or persistence of vascularity before the third month after treatment were not poor prognostic factors. The appearance of vascularity seemed to be an indicator of early failure of the treatment. Conclusion. Color Doppler US is highly effective for the follow-up of patients with recurrent melanoma of the limbs. It provides prognostic factors of treatment failure, which may lead to early modification of the treatment strategy.

[1]  F. Lejeune,et al.  In transit metastases of malignant melanoma treated by high dose rTNFα in combination with interferon-γ and melphalan in isolation perfusion , 1992, World Journal of Surgery.

[2]  B. S. B. John F. Thompson M.B.,et al.  Isolated limb perfusion for melanoma: Effectiveness and toxicity of cisplatin compared with that of melphalan and other drugs , 2005, World Journal of Surgery.

[3]  A. Padhani,et al.  The RECIST criteria: implications for diagnostic radiologists , 2001 .

[4]  W. Sterry,et al.  Efficacy of ultrasound B‐scan compared with physical examination in follow‐up of melanoma patients , 2001, Cancer.

[5]  A. Blum,et al.  Ultrasound examination of regional lymph nodes significantly improves early detection of locoregional metastases during the follow‐up of patients with cutaneous melanoma , 2000, Cancer.

[6]  S. Koscielny,et al.  New hemodynamic approach to angiogenesis: color and pulsed Doppler ultrasonography. , 1999, Investigative radiology.

[7]  S. Koscielny,et al.  Prognostic value of high-frequency sonography and color Doppler sonography for the preoperative assessment of melanomas. , 1999, AJR. American journal of roentgenology.

[8]  D. Vanel,et al.  Value of high-frequency US for preoperative assessment of skin tumors. , 1997, Radiographics : a review publication of the Radiological Society of North America, Inc.

[9]  P. Kam,et al.  Frequency and duration of remission after isolated limb perfusion for melanoma. , 1997, Archives of surgery.

[10]  A. Eggermont,et al.  Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs. , 1996, Journal of the American College of Surgeons.

[11]  G. Balderson,et al.  Hyperthermic isolated limb perfusion for malignant melanoma: Response and survival , 1995, World journal of surgery.

[12]  A. Eggermont,et al.  Isolated perfusion of the limb with high-dose tumour necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma) and melphalan for melanoma stage III. Results of a multi-centre pilot study. , 1994, Melanoma research.

[13]  A. Hart,et al.  Prognostic factors for tumor response and limb recurrence-free interval in patients with advanced melanoma of the limbs treated with regional isolated perfusion with melphalan. , 1994, Surgery.

[14]  J. Thomas,et al.  Treatment of cutaneous metastases from malignant melanoma using the carbon-dioxide laser. , 1993, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[15]  R. Mirimanoff,et al.  Regional therapy of melanoma. , 1993, European journal of cancer.

[16]  S. Carlini,et al.  Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion , 1989, Cancer.

[17]  C. Karakousis,et al.  Prognostic parameters in recurrent malignant melanoma , 1983, Cancer.

[18]  E. V. van Slooten,et al.  Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions. , 1982, European journal of cancer & clinical oncology.

[19]  R. F. Ryan,et al.  Chemotherapy of Cancer: Regional Perfusion Utilizing an Extracorporeal Circuit , 1958, Annals of surgery.